1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsFiscal Year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) is sponsored by Department of Defense (DoD). The DMDRP is currently accepting applications for two award mechanisms.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
You are using an outdated browser. Please upgrade your browser to improve your experience. U.S. Department of War organization.
Due to routine system maintenance the CDMRP website will be unavailable from COB 24 April - 27 April COB.
DEPARTMENT OF WAR - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS Transforming Health Care through Innovative and Impactful Research FY26 Duchenne Muscular Dystrophy Research Program FY26 Duchenne Muscular Dystrophy Research Program (DMDRP) Synopsis of FY26 DMDRP Award Mechanisms - (Adobe PDF) - provides a brief description and key elements of the award mechanism.
Program Announcement/Instructions Clinical Translational Research Award Pre-Application (Letter Of Intent): September 4, 2026 5:00 p. m. Eastern Time (ET) September 18, 2026 11:59 p.
m. ET Pre-Application (Letter Of Intent): September 4, 2026 5:00 p. m.
Eastern Time (ET) September 18, 2026 11:59 p. m. ET For further information, please send e-mail to: CDMRP Webmaster - for download-related questions Help@ebrap.
org - for program announcement-related questions FY14 BCRP Recommended for Funding List
According to the current listing, eligibility includes: Researchers and institutions specializing in Duchenne muscular dystrophy research. Confirm the full requirements in the official notice before applying.
Fiscal Year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) is funded by Department of Defense (DoD). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read article